Bindinglaw

US · guidance

CMS SOM App. C, Tag D5203

§493.1232 Standard: Specimen identification and integrity

activein force · 2026-07-22 – presentas-observed

The laboratory must establish and follow written policies and procedures that

ensure positive identification and optimum integrity of a patient’s specimen from

the time of collection or receipt of the specimen through completion of testing and

reporting of results.

Interpretive Guidelines §493.1232

The regulation provides laboratories the flexibility to establish a system that ensures

positive patient identification through specimen collection, labeling, accessioning,

processing, (e.g., aliquoting), storage, testing, and reporting of results. Review the

laboratory’s system (policy and practices) for ensuring positive patient identification

from specimen collection through reporting of results.

Optimum integrity of a patient’s specimen is determined according to the test

methodology utilized by the laboratory and the manufacturer’s instructions. Review the

manufacturer’s instructions for performance of each test method to ensure the specimen

is appropriate for the test system, is stored and preserved properly (e.g., maintained at

room temperature, kept on ice, separated and frozen or refrigerated), and analyzed within

the limitations of the test methodology. For specimen integrity problems in the

preanalytic system, see also D5311.

The laboratory must have a procedure to ensure that special handling of specimens is

maintained throughout the testing process when necessary (e.g., GC cultures and

GC/Chlamydia probes, blood gas specimens, and DNA probes).

Probes §493.1232

How does the laboratory ensure positive identification of patient specimens through all

phases of testing, especially when similar patient identification information (e.g., address,

sex, names, timed specimens, and birth dates) exists?

How does the laboratory ensure that special handling of specimens (as specified in the

laboratory’s procedure manual) is maintained throughout the testing process?

Does the laboratory process patient specimens using separate (distinct) or unique

identifiers in order to avoid mislabeling, specimen mix-ups, incorrect test request entry,

incorrect entry of test results in the Laboratory Information System (LIS), and incorrect

reporting of results?

History

Rev. 233; Issued: 09-12-25; Effective: 09-12-25; Implementation: 09-12-25

Provenance

Source
cms.gov
Retrieved
2026-07-22
Edition
som-2026-07-22
Content hash
e7f836d7c7eb00f168dc47b168f0cc0f9422c6565735d37ee7d50ac1f164c9df
View the official source →

The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.

Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.

Coverage · API docs

Bindinglaw

Point-in-time US law with the receipt attached. Source URL, retrieval time, content hash, and validity dates on every answer.

curl api.binding.law/v1/law/coverage

© 2026 binding.law · a Jubal, Inc. productAttorneys and firms never pay. Ever.